COM:ADAPTHEALTH
AdaptHealth Corp.
- Stock
Last Close
9.89
22/11 21:00
Market Cap
1.30B
Beta: -
Volume Today
735.92K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 9.11M - | 38.50M 322.75% | 90.94M 136.22% | 125.42M 37.92% | 120.70M 3.77% | |||
average payables | 50.64K - | 13.27M 26,103.37% | 108.77M 719.69% | 219.53M 101.84% | 235.27M 7.17% | 111.25M 52.71% | ||
average receivables | 13.48M - | 101.81M 654.95% | 268.27M 163.51% | 359.52M 34.02% | 374.03M 4.04% | |||
book value per share | 0.00 - | 7.86 1,010,102.37% | -3.25 141.38% | 7.52 331.29% | 16.36 117.57% | 16.08 1.72% | 10.85 32.53% | |
capex per share | -0.04 - | -0.76 1,689.00% | -1.61 112.52% | -2.92 81.24% | -2.51 13.94% | |||
capex to depreciation | -0.08 - | -0.48 469.70% | -0.79 63.39% | -1.11 41.47% | -0.88 20.90% | |||
capex to operating cash flow | -0.07 - | -0.20 185.22% | -0.74 262.91% | -1.05 41.96% | -0.70 32.94% | |||
capex to revenue | -0.01 - | -0.04 622.52% | -0.08 120.10% | -0.13 59.08% | -0.11 19.97% | |||
cash per share | 0.00 - | 8.13 211,854.73% | 0.43 94.67% | 1.90 339.80% | 1.18 37.80% | 0.34 70.89% | 0.57 66.39% | |
days of inventory on hand | 58.66 - | 23.97 59.14% | 22.37 6.69% | 18.26 18.34% | 15.25 16.52% | |||
days payables outstanding | 85.34 - | 77.90 8.72% | 45.06 42.15% | 31.81 29.41% | ||||
days sales outstanding | 53.69 - | 61.03 13.68% | 53.52 12.31% | 44.13 17.54% | 44.36 0.52% | |||
debt to assets | 0.56 - | 0.71 - | 0.44 37.61% | 0.45 2.18% | 0.45 1.18% | 0.51 14.07% | ||
debt to equity | 7.17 - | -2.20 - | 2.04 192.92% | 1.15 43.89% | 1.08 5.91% | 1.57 45.78% | ||
dividend yield | 0.33 - | 0.47 42.61% | ||||||
earnings yield | -0.00 - | 0.01 298,434.17% | 0.05 627.55% | -0.03 160.28% | 0.05 269.72% | 0.03 46.83% | -0.69 2,677.56% | |
enterprise value | 303.18M - | 306.24M 1.01% | 399.28M 30.38% | 2.68B 570.84% | 5.31B 98.26% | 4.86B 8.46% | 3.20B 34.23% | |
enterprise value over ebitda | -439.39K - | -248.23 99.94% | 10.77 104.34% | -213.36 2,081.14% | 11.02 105.17% | 8.98 18.52% | -5.92 165.87% | |
ev to operating cash flow | -187.39 - | 29.79 115.90% | 13.69 54.04% | 19.26 40.70% | 13.00 32.50% | 6.65 48.84% | ||
ev to sales | 2.18 - | 2.54 16.43% | 2.16 14.67% | 1.64 24.36% | 1.00 38.95% | |||
free cash flow per share | -0.05 - | 0.55 1,155.35% | 2.97 438.11% | 0.57 80.71% | -0.13 122.84% | 1.07 914.22% | ||
free cash flow yield | -0.01 - | 0.05 1,044.82% | 0.08 57.31% | 0.02 70.37% | -0.01 129.06% | 0.15 2,246.68% | ||
graham net net | -0.01 - | 7.85 147,493.14% | -7.70 198.00% | -22.28 189.57% | -21.40 3.98% | -19.99 6.57% | -19.46 2.64% | |
graham number | 0.00 - | 3.44 552,545.43% | 6.30 83.38% | 13.76 118.39% | 21.34 55.07% | 13.67 35.92% | 35.11 156.83% | |
income quality | -0.78 - | 1.10 239.83% | -3.33 404.17% | 1.74 152.32% | 5.11 193.28% | -0.71 113.93% | ||
intangibles to total assets | 0 - | 0 | 0.72 Infinity% | 0.61 15.54% | 0.71 15.56% | 0.71 0.41% | 0.63 10.86% | |
interest coverage | -0.30 - | 2.24 853.21% | 1.81 19.39% | 2.37 31.28% | 1.74 26.57% | -4.59 363.90% | ||
interest debt per share | 0.01 - | 0.13 2,281.55% | 7.74 5,730.11% | 16.16 108.79% | 19.52 20.78% | 18.17 6.92% | 18.04 0.72% | |
inventory turnover | 6.22 - | 15.23 144.72% | 16.32 7.17% | 19.99 22.46% | 23.94 19.79% | |||
invested capital | 7.17 - | -2.20 - | 2.04 192.92% | 1.15 43.89% | 1.08 5.91% | 1.57 45.78% | ||
market cap | 303.13M - | 307.19M 1.34% | 247.68M 19.37% | 1.97B 695.98% | 3.09B 56.71% | 2.58B 16.53% | 979.91M 62.00% | |
net current asset value | -166.49K - | -7.47M 4,386.38% | -154.59M 1,969.70% | -1.06B 584.83% | -2.51B 137.44% | -2.48B 1.48% | -2.39B 3.37% | |
net debt to ebitda | -78.87 - | 0.77 100.97% | 4.09 432.65% | -56.32 1,477.34% | 4.61 108.18% | 4.22 8.53% | -4.10 197.30% | |
net income per share | -0.00 - | 0.07 302,432.46% | 0.54 712.66% | -1.12 306.21% | 1.24 210.53% | 0.52 58.22% | -5.05 1,077.65% | |
operating cash flow per share | -0.05 - | 0.59 1,236.31% | 3.73 527.24% | 2.18 41.44% | 2.79 27.66% | 3.58 28.33% | ||
payables turnover | 4.28 - | 4.69 9.55% | 8.10 72.86% | 11.47 41.67% | ||||
receivables turnover | 6.80 - | 5.98 12.03% | 6.82 14.04% | 8.27 21.28% | 8.23 0.52% | |||
research and ddevelopement to revenue | ||||||||
return on tangible assets | -0.00 - | 0.01 469.54% | 0.20 2,278.25% | -0.08 142.47% | 0.10 222.65% | 0.05 54.91% | -0.41 995.30% | |
revenue per share | 8.13 - | 20.13 147.61% | 19.43 3.44% | 22.14 13.93% | 23.81 7.53% | |||
roe | -0.03 - | 0.01 129.93% | -0.17 2,063.79% | -0.15 10.84% | 0.08 150.80% | 0.03 57.49% | -0.47 1,549.04% | |
roic | -0.00 - | -0.00 3.43% | 0.27 7,569.88% | 0.05 81.09% | 0.04 20.06% | 0.03 24.25% | -0.14 565.38% | |
sales general and administrative to revenue | 0.31 - | 0.08 72.55% | 0.07 19.31% | 0.05 20.03% | 0.06 8.84% | |||
shareholders equity per share | 0.00 - | 7.86 1,010,102.37% | -3.25 141.38% | 7.52 331.29% | 16.36 117.57% | 16.08 1.72% | 10.85 32.53% | |
stock based compensation to revenue | 0.06 - | 0.02 70.73% | 0.01 41.63% | 0.01 26.92% | 0.01 6.88% | |||
tangible asset value | 24.31K - | 245.55M 1,010,102.37% | -150.02M 161.09% | -723.34M 382.17% | -1.65B 127.85% | -1.55B 5.93% | -1.39B 10.44% | |
tangible book value per share | 0.00 - | 7.86 1,010,102.37% | -6.65 184.64% | -13.78 107.21% | -13.05 5.31% | -11.55 11.45% | -10.33 10.60% | |
working capital | -166.49K - | 405.71K 343.69% | 5.26M 1,197.72% | -62.02M 1,277.91% | 170.25M 374.52% | 129.09M 24.17% | 112.02M 13.22% |
All numbers in USD (except ratios and percentages)